Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
P&B INVEST from Liège, company number BE0799090552, closed financial year 2025 with a result of € 22,404 after tax. For that financial year P&B INVEST recorded a gross margin of € 64,523 and equity of € 281,724. Compared with financial year 2024, the result moved from € 21,208 to € 22,404. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.
€ 281,724
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 22,404
▲ 6% vs 2024
Profit after tax over the fiscal year.
€ 113,477
▲ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 266,695.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 45,988 | € 61,949 | € 64,523 | ▲ 4% |
| Profit after taxes | € 18,510 | € 21,208 | € 22,404 | ▲ 6% |
| Equity | € 238,112 | € 259,320 | € 281,724 | ▲ 9% |
| Total debts | € 19,878 | € 20,181 | € 0 | ▼ 100% |
| Cash | € 54,348 | € 91,439 | € 113,477 | ▲ 24% |
| Land & buildings | € 199,202 | € 183,131 | € 162,285 | ▼ 11% |
| Retained profit | € 223,083 | € 244,291 | € 266,695 | ▲ 9% |
| Balance sheet total | € 257,990 | € 279,500 | € 281,724 | ▲ 1% |
Key figures of P&B INVEST, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to P&B INVEST?
What happened at P&B INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 22,404 (▲ 6% vs 2024). Source: NBB ↗
- New establishment in Liège. KBO
- P. RASE MEDICAL SRL became a director. NBB
- KEDZIERSKI BENOIT SRL became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 18,510 profit in 2023 to € 22,404 profit in 2025.
Paid € 21,220 in corporate taxes since 2023.
Best year ever: 2025, with € 22,404 profit.
Management
The stake of Benoît KEDZIERSKI, P.RASE MEDICAL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
P&B INVESTBehind P&B INVEST are P. RASE MEDICAL SRL and KEDZIERSKI BENOIT SRL. The shares are held by Benoît KEDZIERSKI (16.7%) and P.RASE MEDICAL (16.7%).
Directors
According to the 2025 annual accounts
Director · represented by RASE PASCAL
since 2023
Director · represented by KEDZIERSKI BENOIT
since 2023
Shareholders
16.7%
16.7%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue Blonden 66
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0799.090.552
- VAT number
- BE 0799.090.552
- Registered office
- Avenue Blonden 66, 4000 Liège
- Names & denominations
- P&B INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 March 2023
- Peppol
- Not registered